Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Hoglund

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|March 26, 2024
Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessmentsJunjie Ding, Richard M Hoglund, Joel Tarning
Clinical Pharmacology and Therapeutics|November 21, 2020
Response to "Pharmacometric Approach to Evaluate Drug Dosing Adherence"Junjie Ding, Richard M Hoglund, Joel Tarning
Malaria Journal|September 5, 2018
Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar borderRichard M Hoglund, Ronnatrai Ruengweerayut, Kesara Na-Bangchang
Expert Review of Clinical Pharmacology|August 26, 2022
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeuticsThanaporn Wattanakul, Palang Chotsiri, Ivan Scandale, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 6, 2024
Pharmacometric and statistical considerations for dose optimizationPalang Chotsiri, Prasert Yodsawat, Richard M Hoglund, et al.
Plos Neglected Tropical Diseases|March 10, 2022
Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepsideFrauke Assmus, Richard M Hoglund, Frédéric Monnot, et al.
British Journal of Clinical Pharmacology|January 27, 2026
Assessing transporter-mediated rifampin-linezolid interaction using physiologically-based pharmacokinetic modellingHoang Dat Nguyen, Vinh Hoa Pham, Richard M Hoglund, et al.
Clinical Pharmacology and Therapeutics|May 22, 2022
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy VolunteersPalang Chotsiri, Joel Tarning, Richard M Hoglund, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage MalariaThanaporn Wattanakul, Mark Baker, Joerg Mohrle, et al.
Plos Medicine|September 4, 2020
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacologyNicholas J White, James A Watson, Richard M Hoglund, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
CPT: Pharmacometrics & Systems Pharmacology|March 26, 2024
Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessmentsJunjie Ding, Richard M Hoglund, Joel Tarning
Clinical Pharmacology and Therapeutics|November 21, 2020
Response to "Pharmacometric Approach to Evaluate Drug Dosing Adherence"Junjie Ding, Richard M Hoglund, Joel Tarning
Malaria Journal|September 5, 2018
Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar borderRichard M Hoglund, Ronnatrai Ruengweerayut, Kesara Na-Bangchang
Expert Review of Clinical Pharmacology|August 26, 2022
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeuticsThanaporn Wattanakul, Palang Chotsiri, Ivan Scandale, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 6, 2024
Pharmacometric and statistical considerations for dose optimizationPalang Chotsiri, Prasert Yodsawat, Richard M Hoglund, et al.
Plos Neglected Tropical Diseases|March 10, 2022
Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepsideFrauke Assmus, Richard M Hoglund, Frédéric Monnot, et al.
British Journal of Clinical Pharmacology|January 27, 2026
Assessing transporter-mediated rifampin-linezolid interaction using physiologically-based pharmacokinetic modellingHoang Dat Nguyen, Vinh Hoa Pham, Richard M Hoglund, et al.
Clinical Pharmacology and Therapeutics|May 22, 2022
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy VolunteersPalang Chotsiri, Joel Tarning, Richard M Hoglund, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage MalariaThanaporn Wattanakul, Mark Baker, Joerg Mohrle, et al.
Plos Medicine|September 4, 2020
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacologyNicholas J White, James A Watson, Richard M Hoglund, et al.
Pageof 5